Memory Training for Mild Cognitive Impairment
(WMTrain Trial)
Trial Summary
What is the purpose of this trial?
This study will evaluate the efficacy of working memory training in older adults with amnestic mild cognitive impairment (MCI).
Do I need to stop my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment Working Memory Training for Mild Cognitive Impairment?
Is working memory training, like Cogmed, safe for humans?
How is the Working Memory Training treatment different from other treatments for mild cognitive impairment?
Research Team
Alexandru Iordan, Ph.D
Principal Investigator
University of Michigan
Eligibility Criteria
This trial is for older adults who have been diagnosed with amnestic mild cognitive impairment (MCI). Participants must be able to undergo MRI scans, be right-handed, and not have other neurological conditions, significant mental illnesses, sensory impairments that could affect participation, or a history of substance abuse.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo 10 sessions of working memory training, either in-person or online, depending on their group assignment
Follow-up
Participants are monitored for changes in brain activation and cognitive performance after training
Treatment Details
Interventions
- Working Memory Training
Working Memory Training is already approved in European Union, United States, Canada for the following indications:
- Attention Deficit Hyperactivity Disorder (ADHD)
- Learning Disabilities
- Cognitive Impairment
- ADHD
- Learning Disabilities
- Amnestic Mild Cognitive Impairment (MCI)
- ADHD
- Learning Disabilities
- Cognitive Impairment
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Michigan
Lead Sponsor